EPHA2 and ductal breast carcinoma in situ: Then, by analyzing EphA2 expression via immunohistochemistry (IHC) in the same context, we observed a significant upregulation in FEA and DCIS compared to the NME, indirectly confirming the molecular link with miR-1297 (Figure 2f, g).